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Background: Infected percutaneously inserted central venous catheters (PICCs) 
are a problem in hospitalized patients, especially in the neonatal intensive care 
unit. The objective of this study was to assess the risk of infection and other PICC-
associated complications in very low birth weight infants.
Methods: Between January 2005 and December 2006, we studied 412 PICCs inserted 
in 267 neonates with a birth body weight ≤ 1500 g. PICC-related bloodstream infections 
and other complications were recorded and analyzed.
Results: These 412 PICCs were inserted for a mean duration of 16.6 ± 9.9 (SD) days. 
The most common catheter-related complications were catheter-related blood-
stream infection (CRBSI; incidence: 8.3 per 1000 catheter days), followed by cath-
eter occlusion (4.0 per 1000 catheter days), catheter site inflammation (3.5 per 
1000 catheter days), and phlebitis (3.1 per 1000 catheter days). The most common 
pathogen of CRBSI was coagulase-negative staphylococcus (40.1%). Significant risk 
factors of CRBSI included catheters inserted at femoral sites (increased risk of CRBSI 
compared with nonfemoral catheters: 1.76; 95% confidence interval, 1.01−3.07, 
p = 0.045) and a longer duration of PICC placement (p < 0.001). A low birth body 
weight and gestational age were not found to significantly affect the risk of CRBSI.
Conclusion: It is important to avoid inserting a PICC at the femoral site. Strict 
catheter care protocol should also be applied to reduce local site bacterial coloni-
zation and removal of PICCs as soon as they are no longer essential for patient care 
to reduce the incidence of infection.
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1.  Introduction
Percutaneously inserted central venous catheters 
(PICCs) are widely used in the neonatal intensive care 
unit (NICU) and they provide secure venous access 
for safe administration of hyperosmolar solutions. 
However, PICC lines are associated with a number 
of insertion and maintenance problems, including 
clotting, catheter fracture, phlebitis, and catheter-
related bloodstream infection (CRBSI). CRBSI is po-
tentially life-threatening and carries risks of mortality 
or morbidity.1,2 The reported rates of CRBSI range 
from 4.8−16.5 per 1000 catheter-days in the NICU,3−8 
with the smallest and most immature infants being 
at the greatest risk.7,9,10
Prevention of CRBSI is one of the priorities of 
most NICUs because of potential reductions in 
mortality, morbidity, and days of hospitalization. 
Infection rates can be reduced by applying strict 
protocols for PICC care and educating physicians 
and nurses.11−14 Several studies have focused on 
risk factors of CRBSI caused by PICCs and tried to 
promote better surveillance.7,10−12 Although PICC 
insertion is a well-established risk factor for CRBSI, 
the relationship of CRBSI with many variables, in-
cluding birth body weight, gestational age, sex, 
body weight when the PICC is placed, age in days 
when the PICC is placed, site of PICC (femoral vs. 
nonfemoral), time spent for PICC insertion, and 
duration of PICC placement has not been well stud-
ied. Therefore, we conducted a study to determine 
the contributing factors leading to increased risks 
of CRBSI. All PICCs were inserted into central veins 
since the use of noncentral PICCs have been shown 
to be less effective15 and a study of 1266 PICCs 
showed that true central placement of the cathe-
ter tip results in fewer complications.16
2.  Patients and Methods
2.1.  Study population
The study was conducted by retrospectively re-
viewing medical records of 392 premature infants 
with a birth weight of less than 1500 g. These in-
fants were admitted to the NICU of Chang Gung 
Children’s Hospital, which is a 49-bed NICU medi-
cal center in northern Taiwan, between January 
2005 and December 2006. This study was approved 
by the institutional review board of Chang Gung 
Children’s Hospital, and we obtained informed 
consent from the patients’ parents before we in-
serted PICCs. After excluding 32 neonates because 
of their early mortality unrelated to PICC inser-
tion, 61 neonates without a PICC, and 24 patients 
for whom detailed records were unavailable, we 
enrolled a total 275 very low birth weight (VLBW) 
infants with a total of 412 PICCs.
2.2.  PICC placement
In our NICU, a PICC is usually placed in a VLBW infant 
when an inability to tolerate adequate oral feeding 
beyond 7 days of life is expected, or when hyper-
osmolar infusions need to be given for more than 
1 week. All PICCs were Vygon (Paris, France), 30 cm 
long with a single lumen, 0.3 mm × 0.6 mm in size, and 
were silicone catheters with an introduction can-
nula. All PICCs were inserted under a strict sterile 
environment by an experienced nursing specialist 
who had been performing this procedure for more 
than 15 years. Residents or clinical neo natologist 
fellows inserted the catheters under supervision and 
followed a standardized procedure. The vein se-
lected for cannulation was determined by those who 
performed catheter insertion, and peripheral veins, 
including the greater and lesser saphenous veins of 
the lower extremities, and basilic veins or cephalic 
veins of the upper extremities, were preferred over 
femoral sites. When all other peripheral vascular 
accesses failed, acceptable femoral sites were cho-
sen for insertion. There were no subclavian venous 
insertions and no patients had two PICCs at the 
same time.
Before insertion, the patient’s skin was disin-
fected by rubbing the site of insertion with sterile 
gauze soaked in a solution of 10% povidone-iodine 
containing alcohol (75%). Correct catheter tip po-
sition was confirmed by chest X-ray. We followed a 
strict protocol to place the tips of PICCs inserted 
in the upper extremities in the superior vena cava 
before the right atrium, and to ensure that PICCs 
inserted in the lower extremities were above the 
T10 level. After successful insertion, the same dis-
infectant solution was applied to the insertion site, 
normal saline was used to decolorize, and the area 
was covered by a transparent dressing. Any manip-
ulations on the catheters were performed by the 
NICU nurses following a standardized protocol.
2.3.  Records of PICCs
Nurses recorded the following details of each PICC 
into the computerized database: the site of insertion, 
the time spent for the procedure, the fixation point 
of the PICC, success or failure of the insertion, and 
all catheter-related complications. We calculated the 
time spent for insertion, including site preparation, 
sedation, successful cannulation, and complete fix-
ation of the PICC. The maximum duration for a 
PICC placement was one month, and a second cath-
eter was placed if needed, as judged by the at-
tending physicians. Confirmation of catheter-related 
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complications and the decision for removal of a 
PICC, either elective or because of complications, 
were made by the attending neonatologists or senior 
residents on duty. If an infant developed clinical 
symptoms and signs of sepsis, a single blood culture 
was usually peripherally obtained and empiric an-
tibiotics were administered. The infected catheters 
were always removed when cultures were positive 
for gram-negative sepsis or the patient was unre-
sponsive to intravenous antibiotics for coagulase-
negative staphylococcus infection. Phlebitis, catheter 
fracture, extravasation, thrombosis, and catheter 
site inflammation were definitive indications for 
removal of the PICC.
2.4.  Definitions
CRBSI in this study was defined as at least one pos-
itive blood culture obtained from a peripheral vein, 
the presence of clinical features consistent with 
bloodstream infection in the presence of a PICC in 
position, and no other site of infection. If coagulase-
negative staphylococcus was identified in infants, 
only those with clinical septic symptoms and re-
ceiving a course of intravenous antibiotics decided 
by attending physicians for at least 7 days were re-
garded as significant. We considered phlebitis present 
when a linear red streak developed along the su-
perficial veins from the insertion site. Thrombosis 
was suspected when leg swelling with or without 
poor perfusion developed. Catheter site inflamma-
tion was diagnosed in the presence of lymphangi-
tis, purulence, or at least two signs of inflammation 
(erythema, tenderness, increased warmth, or in-
duration). No bacterial pathogens were identified 
from blood cultures for both phlebitis and catheter 
site inflam mation. Cholestasis was defined as direct 
bilirubin ≥ 1.5 mg/dL. Rupture was defined as com-
pletely broken PICCs, rather than simple leakage. 
Extravasation was defined as the dislodgement of 
a PICC. Time to complication was calculated from 
the day of insertion to the day any catheter-related 
complication was recognized.
2.5.  Statistical methods
The incidence of infection was measured as infection 
episodes per 1000 catheter days (incidence den-
sity). Different subgroups in several suspected risk 
factors were analyzed by binary logistic regression 
models. The χ2 test, Fisher exact test, and nonpara-
metric test were used for categorical data, and 
either the Student’s t test or the Wilcoxon/Mann-
Whitney test was used for continuous variables. 
Multiple logistic regression analysis was used to 
determine the most significant contributors to CRBSI. 
All statistics were performed using the commercially 
available software SPSS software for Windows (ver-
sion 13.0; SPSS Inc., Chicago, IL, USA), and p < 0.05 
was considered statistically significant.
3.  Results
The clinical characteristics of low birth weight 
premature infants with PICCs are summarized in 
Table 1. A total of 275 neonates with 412 PICCs were 
Table 1  Features of the study population
Features*
Total patient 275
Total PICC  412
BBW (g) 1033.8 ± 279.8
BW when PICC was inserted (g) 1121.1 ± 449.2
GA (wk) 28.0 ± 2.6
Sex
 Males 148 (53.7)
 Females 127 (46.3)
Time requirement for PICC 39.5 ± 25.6
 insertion (min)
Day of life when PICC 7 (4−29.8)
 was inserted (d)
Duration of indwelling PICC (d) 19.6 ± 9.9
Site of PICC insertions 
 Nonfemoral site 241 (58.5)
 Femoral site 171 (41.5)
Conditions for PICC removal 
 Indicated for early removal 156 (37.9)
  Documented complications† 133 (32.3)
  Suspected clinical sepsis 23 (5.6)
 Elective removal 256 (62.1)
  No use 177 (43.0)
  30-d limit 79 (19.1)
Time to complications (d)  11.6 ± 8.6
PICCs (n) 1 (1−2)
Duration of TPN (d) 28 (17−52)
Length of ventilator use (d) 46 (27−76)
Length of hospitalization (d) 76 (54−104)
Maximum serum creatinine  1.44 ± 3.3
 level (mg/dL)
Necrotizing enterocolitis 26 (9.5)
Cholestasis 78 (28.4)
Mortality  17 (6.2)
*Values expressed as n (%), median (interquartile range) or 
mean ± SD; †documented complications included removal of 
PICCs due to phlebitis, catheter site inflammation, throm-
bosis, leakage, rupture, extravasation, occlusion and epi-
sodes of catheter-related bloodstream infection with PICC 
removal. BBW = birth body weight; BW = birth weight; 
GA = gestational age; PICC = percutaneously inserted central 
venous catheter; TPN = total parenteral nutrition.
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included in this study. Of them, 83 (30.2%) neonates 
had PICCs inserted more than once. There was a 
total of 241 PICCs placed at nonfemoral sites in 152 
infants and 171 PICCs placed at femoral sites in 
146 infants. PICC use was more prevalent among in-
fants with a low birth body weight and gestational 
age. PICCs were more frequently inserted at the fem-
oral site when PICCs had been inserted previously 
in a patient or when patients had prolonged hospi-
talization (data not shown).
The indwelling duration of PICCs was 19.6 ± 9.9 
days. A total of 62.1% of catheters removed electively 
were indwelling for 25.1 ± 6.6 days, and 37.9% of 
catheters removed because of documented com-
plications or suspected clinical sepsis were in-
dwelling for 10.7 ± 7.7 days. Although 67 episodes of 
documented catheter-related infection developed, 
26 of them were successfully treated with intrave-
nous antibiotics without PICC removal. The times 
from the placement of PICCs to the occurrence of 
complications were 16.4 ± 8.4 days, 4.9 ± 3.7 days, 
and 10.8 ± 9.6 days for CRBSI, phlebitis and catheter 
site inflammation, respectively. The overall survival 
rate of the infants was 93.8% and a total of 17 pa-
tients died. Four of them died of sepsis, and the 
other 13 patients died of prematurity-associated 
complications such as necrotizing enterocolitis, late 
sequelae of intraventricular hemorrhage, and con-
genital anomalies.
All catheter-related complications and their inci-
dences are listed in Table 2. All of these catheter-
related complications occurred in different cases. 
Among a total of 67 episodes of CRBSI, the most com-
mon pathogen was coagulase-negative staphylococ-
cus (40.1%), followed by Staphylococcus aureus 
(16.4%), Enterococcus spp. (13.4%), and Klebsiella 
spp. (13.4%). There were 8093 catheter days in all 
of the PICCs. When different pathogens were iden-
tified from peripheral blood and PICCs after re-
moval, the pathogen identified from peripheral 
blood was considered as the real pathogen. We did 
not find any complications from the insertion pro-
cedure. Although four patients died of late-onset 
sepsis (2 infants died of Klebsiella pneumoniae and 
Acinetobacter baumannii sepsis, and another 2 had 
Candida albicans sepsis), there were no life-
threatening events directly related to PICCs, such 
as cardiac tamponade, pericardial effusion, massive 
bleeding, or pneumothorax.
The independent variables analyzed to evaluate 
the risk factors of catheter-related sepsis (CRS) 
are listed in Table 3. These variables included birth 
body weight, gestational age, sex, body weight when 
the PICC was placed, age in days when the PICC 
Table 2  Catheter-related complications and pathogens of catheter-related infections
 Catheters (n = 412)
Complications* Catheter-days (n = 8093)
 n (%) n/1000 catheter-days
Catheter-related sepsis 67 (16.3) 8.3
Pathogens
 Coagulase-negative Staphylococcus 27 (40.1) 3.3
 Staphylococcus aureus 11 (16.4) 1.4
 Enterococcus 9 (13.4) 1.1
 Klebsiella† 9 (13.4) 1.1
 Enterobacter‡ 1 (1.5) 0.12
 Acinetobacter baumannii 4 (6.0) 0.5
 Escherichia coli 1 (1.5) 0.12
 Pseudomonas aeruginosa 1 (1.5) 0.12
 Candida 4 (6.0) 0.5
Phlebitis 25 (6.1) 3.1
Thrombosis 1 (0.2) 0.12
Catheter site inflammation 28 (6.8) 3.5
Leakage 7 (1.7) 0.9
Rupture 10 (2.4) 1.2
Extravasation 4 (1.0) 0.5
Occlusion 32 (7.8) 4.0
*All events, including catheter site inflammation, phlebitis, and thrombosis occurred in different cases; †includes K. oxytoca and 
K. pneumoniae; ‡includes E. cloacae and E. aerogenes.
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was placed, site of PICCs (femoral vs. nonfemoral), 
time spent for PICC insertion, and duration of PICC 
placement. Using bivariate analysis, infants with a 
birth body weight less than 750 g had a higher inci-
dence of CRBSI compared with those with a larger 
birth body weight, although this difference did not 
reach statistical significance (p = 0.076). Patients 
with a gestational age longer than 32 weeks had a 
significantly lower risk of CRBSI than those with a 
shorter gestational age (both p = 0.001). A longer 
duration of PICC placement significantly increased 
the risk of CRBSI; a placement of more than 20 days 
had a 4.66-fold increased risk of developing a CRBSI 
compared with a placement of less than 10 days 
(95% confidence interval [CI]: 1.93−11.28). The 
site of PICC insertion also affected the incidence 
of CRBSI. Femoral catheters had a 1.94-fold in-
creased risk of developing a CRBSI compared with 
nonfemoral catheters (95% CI: 1.15−3.29).
Multiple logistic regression analysis showed that 
the only two significant contributors to CRBSI were 
insertion of PICCs at femoral sites (odds ratio: 
1.76; 95% CI: 1.01−3.07; p = 0.045) and the duration 
of PICC placement (p < 0.001). When PICCs were 
inserted, neither birth body weight, gestational age, 
nor body weight were significantly associated with 
the incidence of CRBSI. For additional delineation 
of the effect of duration of PICCs versus CRBSI, a 
receiver operating characteristic curve showed 
that the area under the curve was 0.68.
4.  Discussion
Our study demonstrated that PICCs are a safe device 
and that they provide reliable intravascular access 
for VLBW infants. No life-threatening complications 
developed that were directly related to PICCs. 
Table 3  Logistic regression models for odds ratios of catheter-related infections for different risk factors
Variables
 Infection rate (%)  
Relative risk
 95% confidence
 (case no./total no.)  interval
BBW (g)
 ≤ 750 22.4 (15/67) Reference
 751−1000 12.5 (16/128) 2.02 0.93−4.38
 1001−1250 16.2 (17/105) 1.49 0.68−3.24
 1251−1500 17.0 (19/112) 1.41 0.66−3.01
BW when PICC was inserted (g)
 ≤ 750 19.1 (13/68) Reference
 751−1000 14.2 (15/106) 0.70 0.31−1.58
 1001−1250 22.2 (28/126) 1.21 0.58−2.52
 ≥ 1251 10.0 (11/110) 0.47 0.20−1.12
Sex
 Male 14.3 (33/231) Reference
 Female 18.8 (34/181) 1.39 0.82−2.34
GA (wk)
 < 27  16.9 (23/136) Reference
 27−31  17.3 (41/237) 1.03 0.59−1.80
 > 32  7.7 (3/39) 0.41 0.12−1.44
Site of PICC insertion
 Nonfemoral site* 12.4 (30/241) Reference
 Femoral site 21.6 (37/171) 1.94 1.15−3.29
Time requirement of PICC
 insertion (min)
 ≤ 30  15.4 (31/201) Reference
 31−60 19.3 (29/150) 1.31 0.75−2.30
 ≥ 61  10.0 (6/60) 0.61 0.24−1.54
Duration of PICC placement (d)
 ≤ 10  6.2 (6/97) Reference
 11−20  10.2 (10/98) 1.72 0.60−4.94
 ≥ 21  23.5 (51/217) 4.66 1.93−11.28
*Nonfemoral sites included the greater and lesser saphenous veins of the lower extremities, and basilic veins or cephalic veins of 
the upper extremities. BBW = birth body weight; BW = body weight; PICC = percutaneously inserted central venous catheter; 
GA = gestational age.
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In the long-term, catheter-related bloodstream in-
fections represent the most common complications. 
The major findings in our study were that a long 
duration of PICC placement and PICCs inserted at 
femoral sites significantly increased the risk of 
CRBSI in VLBW infants in our NICU. The findings in 
our study are not consistent with findings in several 
other studies where a low gestational age or low 
birth body weight significantly increase the risk of 
CRBSI.10,17−19. Because we used PICCs with a small 
internal caliber, this was not suitable for blood trans-
fusion, measurement of central venous pressure, and 
blood withdrawal for bacterial culture. Therefore, 
we never took blood cultures from PICCs, and our 
applied definition of CRBSI was slightly different 
from that in other studies.7,10,17
In our study population, two-thirds of inserted 
PICCs were removed electively, and the incidences 
of CRS and phlebitis were comparable with those of 
other large scale studies.4−7,11 The average catheter 
life was nearly 3 weeks, which provided prolonged 
uninterrupted intravascular access, and this finding 
is similar to that of other studies.10,13,17 However, 
our incidence of thrombosis was quite low compared 
with that of previous studies,17,20−22 which reported 
the incidence of thrombosis to be approximately 
20−30% in critically ill neonates, especially when 
catheters were inserted at the femoral site. In our 
NICU, we do not routinely give a continuous infusion 
of heparin. Because duplex Doppler ultrasonography 
was not routinely performed to determine whether 
there was thrombosis in our NICU and most cases 
of thrombosis might be asymptomic,20−22 we might 
have underestimated the occurrence of catheter-
related thrombosis.
Some studies have recommended not inserting 
a PICC at the femoral site of low birth body weight 
infants23,24 because of a high incidence of CRS and 
a high risk of thrombosis. When a patient in our NICU 
was hospitalized for a prolonged period, peripheral 
vascular access could be damaged by previous IV 
insertions and the femoral site was an available al-
ternative. Although there were some advantages to 
inserting a PICC at the femoral site, including easy 
accessibility and a high success rate, we recommend 
that the peripheral vein should be used rather than 
the femoral vein for PICC insertions. Femoral site 
insertion of a PICC provided nearly 3 weeks of vas-
cular access when all peripheral veins were un-
available, but there is a need to be aware of the 
signi ficantly higher risk of catheter-related infection 
when a catheter is inserted at femoral site; there-
fore, this procedure should be avoided if possible.
The time from the placement of the PICC to 
the oc currence of catheter-related infection was 
16.4 ± 8.4 days, which is similar to that of previous 
studies.7,10,17 Other studies have also concluded 
that the CRBSI risk increases with the duration of 
time that the catheters are in place.17,19,25 Because 
an increased duration of catheterization increases 
the risk of skin colonization26−28 and more skin or 
catheter exit site colonization is associated with an 
increased risk of CRBSI,25−29 it seems reasonable 
that the occurrence of CRBSI could increase with a 
longer period of PICC placement. However, the re-
ceiver operating characteristic curve performed to 
delineate the effect of duration of PICCs versus 
CRS showed that the area under the curve was only 
0.68. Therefore, we could not determine the optimal 
timing for removal of PICCs to prevent subsequent 
CRBSI.
There are some limitations of this study. It was 
not a prospective, randomized, controlled study, 
and several biases could have affected the results. 
Confirmation of all conditions or complications of 
PICCs was not uniformly documented, and the de-
cisions of management for some PICCs may have 
varied depended on the different attending physi-
cians. In addition, selection of the site for PICC in-
sertion was not randomized.
In summary, this study confirmed that a long in-
dwelling duration of PICCs and placement of PICCs 
at the femoral site were significant contributors of 
CRBSI. To reduce the incidence of infection, it is im-
portant to apply strict catheter insertion and care 
protocols, including avoidance of contamination 
and proper skin cleansing and dressings, to reduce 
local site colonization, and remove PICCs as soon 
as they are no longer needed for patient care.
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